Frailty In Cardiac Surgery Copenhagen Study (FICS)

April 2, 2019 updated by: Christian Holdflod Møller, Rigshospitalet, Denmark

Background:

Over the past decades there have been seen an increase in life expectancy in Denmark. One of the consequences is that the patients who need heart surgery have a higher average age and some of these patients have a fragile physique that increases the risks of major surgery.

In cardiac surgery, there are different types of scoring system for assessing the preoperative risk of death associated with surgery. Among them are EuroSCORE and STS systems the most used.

This study evaluate the preoperative risk using the frailty score system, CAF (comprehensive assessment of frailty), based on an assessment of the patient's physical condition. If the patient has a lower than expected physical condition, the patient is frail. The assessment of the physical condition generated from questions about the patient's medical history and physical activity as well as performing less physical tests, consisting of strength, balance and walking speed.

Purpose:

A prospective observational study, who investigates how many of the patients who must undergo heart surgery, that is frail. Then compare the patients who are frail with non-frail patients in terms of complications, mortality and quality of life after the procedure. By use of CAF score the patients are scored frail or non-frail. There is planned a further study which compare degree of kidney injury in frail with non-frail patients. Our assumption is that patients which are frail, have an increased risk of complications and longer hospital stay, higher consumption of intensive days and more readmissions. Using frailty score in combination with the existing score systems EuroSCORE and STS score, are believed to be a better predictor of complications following heart surgery.

Method:

FICS study is a prospective observational study of patients undergoing cardiac surgery in the cardiothoracic department of Rigshospitalet. Planned to enroll 600 patients over a two year period. The study consists of various smaller physical test and questions. Which is used to assess whether the patient is frail and not frail.

Postoperatively follow-up after 30 days with a phone call and after 12 months through danish data register. At the both follow-up times, data are collected on the somatic readmissions / diagnoses and vital status through the national register and review of relevant journal notes. Afterwards comparing complications and mortality.

Who can enter:

One patients can be included if the following criteria are met: Age> 65 years, Elective or subacute surgery, CABG (coronary artery bypass grafting),valve substitution or combination of these

If one or more of the following criteria are met, the patient is not included in the study:

Acute surgery, Clinical unstable, Severe neuropsychiatric impairment, Uncooperative (psychiatric diagnosis) and Re-operations.

Side effects, risks and disadvantages:

Today preoperative risk assessment are assessed by EuroSCORE. Introduction of CAF, frailty score will not expose patients to the risk or side effect, since the course or treatment does not change.

Economy:

There are considered that the study are economically justified, since hypothetically this would lead to fewer readmissions, fewer days in intensive care and shorter hospital.

Acquisition:

The patients will in this trial be over 65 years old and must have completed elective or subacute cardiac surgery. They will receive participant information and thus the opportunity to read about the study before the first appearance.

At first appearance they meet our project assistant and get here verbal information about the study, where also questions can be answered. Subsequently, the patients will be asked to sign a consent form.

Publication of test results / research ethics statement:

The knowledge and results obtained through the survey will provide essential scientific information of significance for the future course and treatment of patients undergoing cardiac surgery with regard to the number of hospital days, intensive days and readmissions. Thus, the investigator believes that the study is appropriate and ethically

Study Overview

Detailed Description

Background:

In general, patients referred to cardiac surgery are aging. An increasing number of patients are now older than 70 years. [1]This older population of patients undergoing cardiac surgery often has several comorbidities and has an increased risk of complications and mortality compared to the younger patients.[1,2] Furthermore, several studies have shown that elderly patients with cardiovascular diseases may be frail. Frailty is a term used to assess the true biological status of a patient and defined as a patient's impaired resistance to stressors due to a decline in physiologic reserve.[3-8] In cardiac surgery there are several risk scores to assess 30-day mortality exists. The most common are the European system for cardiac operative risk evaluation (EuroSCORE) I, EuroSCORE II and the Society of Thoracic Surgeons (STS) score. However, the EuroSCORE seems to have a tendency to overestimate the perioperative risk in the elderly population and opposite the STS score a tendency to underestimate the risk. One of the reasons for this may be that none of the risk scores incorporate the biological status of the patients.[9-11] Within the last 5 years a few studies evaluating different 'frailty scores' in cardiac patients has been published. [3-6,8,12-16] None of these frailty risk scores are fully validated and therefore widely adopted. In a German single center study of 400 patients undergoing elective cardiac surgery and aged 74 or above frailty was assessed by the comprehensive assessment of frailty (CAF) score. The CAF scores assess weakness, self-reported exhaustion, slowness of gait speed, low activity and physical performance. [14,15] The CAF score correlates well with the EuroSCORE and STS score, but is a very complex and time consuming risk score. In an effort to make the test more clinical practical a simpler version of the CAF score has been developed. The 'frailty predicts death one year after elective cardiac surgery test' (FORECAST) includes; chair rise, self-reported weakness, stair climbing, two physicians estimation of frailty and serum creatinine level. [14,17]

Aim:

In an observational prospective study, we will identify and describe the number of frail patients undergoing first time cardiac surgery in our department, compare the risk of short-term and long-term complications and compare quality of life in frail versus non-frail patients. Frailty will be assessed with the CAF score. In a substudy we will analyze the risk of renal insufficiency.

Hypothesis:

Patients deemed frail using the CAF score have increased risk of short-term and long-term complications. With the frailty score in addition to EuroSCORE or STS score, we can better predict complications compared to EuroSCORE or STS score alone.

Method:

A) Patients/study population:

FICS study is a prospective observational study of elderly patients undergoing cardiac surgery at the Department of Cardiothoracic Surgery, Rigshospitalet, Copenhagen University Hospital, Denmark. Expect to include 600 patients during a two years inclusion period. With a minimum of 12 month inclusion period, but all included in the analysis, with a maximum follow-up time.

B) Inclusion criteria:

  1. All patients aged above 65 years old
  2. Patients referred to elective and subacute cardiac surgery
  3. All undergoing CABG (coronary artery bypass grafting), valve replacement and CABG with valve replacement.

C) Exclusions criteria:

  1. Emergent surgery
  2. Clinically unstable
  3. Severe neuropsychiatric impairment
  4. No cooperation (psychiatric diagnosis).
  5. Reoperations

D) Follow-up:

Patients are followed after discharge by searching The Danish National Registry, which contains informations an all somatic hospital admissions. From which there will be collected a copy of the patient record for all hospital admissions. Patient records will be assessed for pour predefined outcome measures.

Information about vital status will be achieved by searching the Danish Central Civil Register. The cause of death will be obtained from patients records and death certificates.

After 30 days we will contact the patients through phone to ask about their quality of life and intake/changes in medicine and again a follow up in Danish Central Civil Register at 12 month.

E) Substudies:

Study 1, Short-term follow-up:

This study describe the proportion of frail patients in our department undergoing cardiac surgery. We will further compare the number of complications between the two groups.

30-day follow-up comparing frail vs non-frail patients undergoing cardiac surgery:

Primary outcome:

In this study the primary outcome will be 30-day all-cause mortality in frail vs. non-frail patients (hospital mortality or death within 30 days postoperatively).

Secondary outcomes: MACCE (Major Adverse Cardiac and Cerebrovascular Events) including:

  • AMI
  • Stroke
  • Mortality

Tertiary outcomes:

  • Stroke
  • Renal failure until discharged:
  • Prolonged ventilation (>24 h)
  • Days in intensive care unit (ICU)
  • Readmission in ICU
  • Deep sternal wound infection (need for operative intervention and antibiotic therapy, with positive culture)
  • Need for reoperation (major bleeding)
  • Perioperative complications ex gastrointestinal complication (ischemia, gastric ulcer)
  • Days of hospitalization
  • Discharged to other hospital or nursing home for ongoing medication or rehabilitation and how many days until discharged to home

Study 2, Long-term follow-up:

This study do a follow up, so the last one included is follow minimum 12 month. And the first one included is followed up until the last is recruited.

12 month follow-up in frail vs non-frail patients undergoing cardiac surgery:

Primary outcome:

In this study the primary outcome is all-cause of mortality after 12 month in frail vs. non-frail patients.

Secondary outcomes: MACCE (Major Adverse Cardiac and Cerebrovascular Events) including:

  • AMI:
  • Stroke
  • Mortality

Tertiary outcomes:

  • Discharged to other hospital or nursing home for ongoing medication or rehabilitation and how many days until discharged to home
  • Prolonged hospitalization ( > 14 days)
  • Number of Re-hospitalization
  • New diagnosis and medication ( changes and new)
  • Social support (need for more help, both care and tools)
  • Other complications.

Study 3,Predicting postoperative Acute Kidney Injury (AKI) in frail vs. non-frail patients undergoing cardiac surgery:

AKS is a major complication after cardiac surgery and associated with increased mortality and morbidity. It has been proven that knowing patients renal reserve before surgery is important, both for predicting mortality and AKI outcomes. Since early detection of these patients may contribute to improving outcomes. Estimation of the renal reserve by Serum creatinine, eGFR, Serum cystatin C, Urinary neutrophil gelatinase-associated lipocalin (NGAL), Cr EDTA Clearance and 24 hr. collection of urine to determine Cr Clearance, protein and albumin. This samples will be collecte on preoperative day, postoperativly day 5 and 3 a follow-up 3 months postoperativley.

Primary outcome: In this study the primary outcome is development of AKI and the severity of AKI in frail vs. non-frail patients, defined as having one of the following:

  • Diuresis <0,5ml/kg/hr. for >6 consecutive hours
  • Serum creatinine raised by >26umol/L within 48 hours
  • serum creatinine rises >1,5 fold from the reference value ( the lowest value recorded within 3 months)

Secondary outcomes:

- Persistent AKI: Having AKI for 48 hours or longer. Study 4, To examine the correlation between frailty score and the other two commonly used surgical risk scores, EuroSCORE and STS and their performance characteristics in patients over the age of 65 undergoing cardiac surgery. This study compare the commonly used risk estimation systems for patients undergoing cardio-surgical procedures, as STS in north America and EuroSCORE in Europe with the frailty score CAF and FORECAST for estimation of mortality and morbidity 30 days and 12 month mortality.

F) The Frailty scoring scale:

CAF:

Evaluation of frailty by using the comprehensive assessment of frailty (CAF) scoring scale of S. Sündermann. [14][15]This is based on a combination of different scoring scales. The first part is based on the Fried criteria: weight loss, self-reported exhaustion, low activity, slowness of gait speed and weakness. Where CAF includes all except weight loss. Self-reported exhaustion are two questions by the original CES-D scale, Center for epidemiological study Depression. Low activity by asking to instrumental activity of daily living (IADL). The IADL used are, walking, housework, outdoor activity, regular sport and others. Following are kilocalories per week calculated by formula: Kilo Cal= (w x frequency of activity x duration of activity)/2. Slowness, speed in meters per second, where the patient walk 4 meters in normal walking speed and weakness through grip strength by pulling as strong as you can the grasp of the dynamometer in kilograms (kg).

The second part is physical performance tests. Testing the balance, how long you can stand still with your feet together, with one feet halfway in front of the other (semi-tandem) and with one feet completely in front of the other one (tandem). At each position the time is measured and put in to frailty table to score points. In the last element of balance the patients is asked to turn around themselves 360 degrees and again the time is obtained. Then testing the body control, get up and down from a chair three times, put on and remove a jacket and pick up a pen from the floor.

The last part is Laboratory tests, including level of serum albumin, Creatinine and calculate Forced expiratory volume in 1 s (FEV1).

At the end two physicians, different from the person observing the CAF test (one cardiac surgeon and one experienced clinician) estimate the patients frailty after the Clinical frailty scale score.

The Clinical frailty scale is from the Canadian Study of Health and Aging, Which is based on a frailty index composed of 70 items, from where you estimate the frailty on a scale 1-7. 1. Very fit: robust, active, energetic, well motivated and fit; these people commonly exercise regularly and are in the most fit group for their age. 2. Well: without active disease, but less fit than people in category 1. 3. Well, with treated comorbid disease: disease symptoms are well controlled compared with those in category 4. 4. Apparently vulnerable: although not frankly dependent, these people commonly complain of being "slowed up" or have disease symptoms. 5. Mildly frail: with limited dependence on others for instrumental activities of daily living. 6. Moderately frail: help is needed with both instrumental and non- instrumental activities of daily living. 7. Severely frail: completely dependent on others for the activities of daily living, or terminally ill.

Finally to get the patients total CAF score, you add each individual test scores together. It has a maximum score of 35 points. That is divided into not frail 1-10, moderately frail 11-25 and severely frail 26-35.

Out from the CAF score, there is a ability to score and use FORECAST (Frailty predicts death One year after elective cardiac surgery test) which include only 5 of CAF items: chair rise, weakness, stair climb, CFS (clinical frailty scale) and Serum creatinine. FORECAST has a maximum score of 14 points, which also is divided into, not frail 0-4, moderately frail 5-7 and severely frail 8-14.[17]

Statistics:

Sample size calculation. Based on the CAF frailty score patients will categorizes into the non-frail group (CAF score <11) or the frail group (CAF score 11 or above). In a previous study Sündermann et al. found that 50% of the patients above 75 years undergoing first time CABG were deemed frail using the CAF score. Furthermore, they observed that 1 year mortality was 7% in the non-frail group versus 14% in frail-group[17] . Based on a power of 80% and a risk of type I error of 5% and the mortality reported above gives an inclusion of at least 300 patients in each group.

Data analysis Categorical data will be presented as numbers and percentages and compared using chi square test or Fischer exact test, as appropriate. Continuous data will be described as means with corresponding standard deviations (SD) and compared using students t-test.

Time to event for the primary and secondary outcomes will be analyzed using a Cox regression model. Survival curves will be illustrated with Kaplan-Meier plots.

A P-value of less than 0.05 will be considered significant.

Administration:

The preoperative testing for frailty will take place in the Department of Cardiothoracic Surgery Rigshospitalet, Copenhagen University Hospital, Denmark.

Economy:

This is a non-profit study. The expenses will be covered by the involving departments at Rigshospitalet. The department of cardiothoracic surgery will cover the costs of a project nurse during the inclusion period.

Ethics:

Today our department use EuroSCORE as a risk score preoperative. The use of frailty score has been used in the department of cardiology the last years.

Admission of frailty scoring in our department is humanly justified since the patient takes no risk and there are no side effects.

We find it financially responsible to introduce, because we hypothetical expect that this will lead to fewer readmissions, fewer ICU days and hospitalization days.

Appendix Definitions Definition MACCE:[18] Non-fatal cardiac arrest: An absence of cardiac rhythm or presence of chaotic rhythm requiring any component of basic or advanced cardiac life support.

Acute myocardial infarction: Increase and gradual decrease in troponin level or a faster increase and decrease of creatine kinase isoenzyme as markers of myocardial necrosis in the company of at least one of the following: ischaemic symptoms, abnormal Q waves on the ECG, ST-segment elevation or depression; or coronary artery intervention (e.g. coronary angioplasty) or a typical decrease in an elevated troponin level detected at its peak after surgery in a patient without a documented alternative explanation for the troponin elevation.

Congestive heart failure: New in-hospital signs or symptoms of dyspnoea or fatigue, orthopnoea, paroxysmal nocturnal dyspnoea, increased jugular venous pressure, pulmonary rales on physical examination, cardiomegaly, or pulmonary vascular engorgement.

New cardiac arrhythmia: ECG evidence of atrial flutter, atrial fibrillation, or second- or third-degree atrioventricular conduction block.

Angina: Dull diffuse substernal chest discomfort precipitated by exertion or emotion and relieved by rest or nitroglycerin.

Stroke: Embolic, thrombotic, or haemorrhagic event lasting at least 30 min with or without persistent residual motor, sensory, or cognitive dysfunction; if the neurological symptoms continue for .24 h, a person is diagnosed with stroke, and if lasting ,24 h the event is defined as a transient ischaemic attack.

Cardiovascular death: Any death, unless an unequivocal non-cardiovascular cause could be established.

Cerebrovascular death: A death caused by cerebrovascular disease.

Renal Failure: diuresis <0,5ml/kg/hr. for >6 consecutive hours or serum creatinine raised by >26umol/L (0,3 mg/dl) within 48 hours or serum creatinine rises >1,5 fold from the reference value at the day 0 to 14.

Study Type

Observational

Enrollment (Actual)

600

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

We expect to include 600 patients during a two years inclusion period. With a minimum of 12-month follow-up, but all included in the analysis, with maximum follow-up time.

Description

Inclusion Criteria:

  • 1) All patients aged above 65 years old 2) Patients referred to elective and subacute cardiac surgery 3) All undergoing CABG (coronary artery bypass grafting), valve replacement and CABG with valve replacement.

Exclusion Criteria:

  • Emergency surgery 2) Clinically unstable 3) Severe neuropsychiatric impairment 4) No cooperation (psychiatric diagnosis). 5) Reoperations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Primary outcome: In this study the primary outcome will be 30-day all-cause mortality in frail vs non-frail patients (hospital mortality or death within 30 days postoperatively).
Time Frame: 30 days
30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
MACCE (Major Adverse Cardiac and Cerebrovascular Events) including: - AMI: - Stroke - Mortality
Time Frame: 30 days
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2016

Primary Completion (Actual)

July 1, 2018

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

December 12, 2016

First Submitted That Met QC Criteria

December 12, 2016

First Posted (Estimate)

December 14, 2016

Study Record Updates

Last Update Posted (Actual)

April 4, 2019

Last Update Submitted That Met QC Criteria

April 2, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H-15004343

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Comprehensive Assessment of Frailty

Clinical Trials on CAF, Comprehensive assessment of frailty

3
Subscribe